Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Gujarat Themis Biosyn Ltd ( (IN:GUJTHEM) ) has issued an update.
Gujarat Themis Biosyn has disclosed the results of a postal ballot conducted via remote e-voting for a special resolution dated 18 March 2026. Shareholders approved the re-appointment of Mrs. Kirandeep Madan as a Non-Executive Woman Independent Director with an overwhelming majority, with overall votes in favour exceeding 99 percent.
The company reported that promoters, public institutions and non-institutional shareholders all participated through e-voting, and the scrutinizer’s report confirmed the validity of the process. The confirmed re-appointment strengthens the company’s board independence and governance structure, a factor closely watched by investors in India’s listed pharmaceutical sector.
More about Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd is an Indian pharmaceutical and biosciences company based in Vapi, Gujarat, with a corporate office in Mumbai. It operates in the manufacturing of bulk drugs and related products, serving domestic and international markets through its listed presence on both BSE and NSE.
Average Trading Volume: 9,899
Technical Sentiment Signal: Hold
Current Market Cap: 32.29B INR
See more data about GUJTHEM stock on TipRanks’ Stock Analysis page.